Sep 7, 2021 | Featured, Federal Issues, Podcast, Uncategorized
On this episode of the podcast, Terry and Kate discuss ovarian cancer — September is Ovarian Cancer Awareness Month — and the pending federal policies that can help those afflicted. They highlight how Biogen has begun administering its new...
Read more
Aug 30, 2021 | COVID-19, Featured, Podcast
On this episode of the podcast, Terry and Bob talk about the threats posed by unregulated hand sanitizers and the risk posed to kids going back to school by the Covid-19 Delta variant. They discuss the latest on booster shots and how these can help further control the...
Read more
Aug 24, 2021 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the war on drug patents, which have come under increasing — and misplaced — scrutiny from critics. They explain how patents incentivize the costly research and development required to bring a drug to...
Read more
Aug 16, 2021 | Featured, Health Insurance, Podcast
On this episode of the podcast, Terry and Bob discuss the rising cost of health insurance, including premiums, deductibles, and copays. They point out how these higher costs disproportionately impact patients with rare and chronic diseases. They explain how insurance...
Read more
Aug 9, 2021 | FDA, Featured, ICER, Podcast
On this episode of the podcast, Bob and Kate, filling in for Terry, discuss the attack on Food and Drug Administration accelerated approvals. They point to the recent criticism of the breakthrough Alzheimer’s drug Aduhelm as Exhibit A. Bob explains how...
Read more
Jul 27, 2021 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the growing barriers to access prescription drugs and the ongoing drug price debate spurred by the recent approval of a new Alzheimer’s drug. Terry discusses ICER’s recent conclusion that the...
Read more
